Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Aquivia Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Aquivia Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 324 · Grade C

Aquivia Health

Visit Aquivia Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 62 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Aquivia Health a bad call — it's best for readers comparing a recurring four-week charge with the full price of a prepaid term. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
70
Transparency
90
32
Access Breadth
93
56
Clinical Oversight
92
76
Track Record
88
54
CoreAge RxBrief Score 94 · 62Aquivia Health

Price, coverage & the tracker

CoreAge RxAquivia Health
Brief Score94/100 (A)62/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$249 every four weeks on the standard recurring plan. $2,327 upfront for 13 shipments.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$339 every four weeks on the standard recurring plan. $3,497 upfront for 13 shipments.

CoverageUS only; restrictions by state, confirmed at intakeConfirm availability for your address and prescription.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Aquivia Health: Compare the four-week charge with the full prepaid amount.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.